Understanding the Findings and Their Policy Implications
As nicotine pouches continue to emerge in markets around the world, regulators face a familiar challenge: how should policymakers respond when new products enter the market before dedicated regulatory frameworks are fully established?
A recent study examining nicotine pouches sold in Karachi has contributed new data to this discussion. The research analysed nicotine content and flavour constituents across multiple nicotine pouch products available in Pakistan, providing one of the first snapshots of product composition in the country’s developing nicotine pouch market.
The findings have generated discussion about product regulation, ingredient oversight, and public health implications. However, understanding what the study actually measured and what it did not measure, is essential for developing evidence-based policy responses.
What the Study Found
Researchers analysed ten nicotine pouch products available in Karachi, examining nicotine content and screening for a wide range of flavour-related compounds.
The study identified numerous flavour constituents across the products tested, including compounds such as menthol, benzyl alcohol, α-terpineol, and carvone. Researchers also found that measured nicotine levels broadly corresponded with the nicotine strengths indicated on product packaging.
Importantly, the study was primarily a compositional analysis. Its purpose was to identify and quantify ingredients present within the products rather than to evaluate health outcomes, toxicological effects, or population-level impacts.
As such, the findings provide useful information about product composition but do not, by themselves, establish whether the detected compounds present a significant health risk at the levels observed.
Composition Does Not Automatically Equal Risk
One of the challenges in public health communication is distinguishing between the presence of a substance and the risk associated with that substance.
Many flavour compounds identified in nicotine pouches are also used in food products, pharmaceuticals, oral care products, and consumer goods. Determining risk requires more than identifying their presence. It requires consideration of exposure levels, toxicological thresholds, route of administration, frequency of use, and comparisons with established safety standards.
The Karachi study did not attempt to perform this type of risk assessment.
This is not a criticism of the research. Compositional studies serve an important role in understanding product characteristics. However, they should be interpreted within the scope of their design.
The presence of flavour compounds alone does not establish harm, just as the absence of a dedicated regulatory framework does not automatically indicate that products are unsafe.
The Regulatory Question Facing Pakistan
The study nevertheless highlights an important policy issue.
Pakistan currently lacks a dedicated regulatory framework specifically designed for nicotine pouches. This creates uncertainty regarding product standards, ingredient disclosure requirements, nicotine limits, labelling expectations, age restrictions, and market oversight.
As nicotine pouches become more widely available, policymakers will increasingly need to determine how these products should be governed.
This challenge is not unique to Pakistan. Many countries have faced similar questions as nicotine pouches, vaping products, and other smoke-free nicotine alternatives have emerged.
The key issue is therefore not whether regulation is needed. Rather, it is what form that regulation should take.
International Approaches
Globally, governments have adopted a variety of approaches toward nicotine pouches.
Some jurisdictions have introduced outright prohibitions. Others have incorporated nicotine pouches into existing tobacco legislation or consumer product frameworks. Several countries have established dedicated requirements relating to nicotine content, ingredient reporting, product notifications, packaging standards, and age restrictions.
Sweden, the United Kingdom, Switzerland, and the Czech Republic provide examples of regulatory systems that permit nicotine pouches while maintaining product standards and consumer safeguards.
These experiences demonstrate that policymakers are not limited to a binary choice between unrestricted access and prohibition.
Harm Reduction and Relative Risk
The regulatory discussion is also influenced by broader debates surrounding tobacco harm reduction.
Unlike cigarettes, nicotine pouches contain no tobacco leaf and involve no combustion. As a result, they do not generate the smoke, tar, or combustion-related toxicants associated with smoking-related disease.
A growing body of scientific literature suggests that nicotine pouches expose users to substantially lower levels of harmful constituents than combustible tobacco products. This does not make them risk-free, but it does place them within a different risk category than cigarettes.
For policymakers, this distinction is relevant when considering regulatory proportionality.
The objective is not simply to regulate nicotine products, but to ensure that regulation reflects available evidence regarding relative risk while maintaining strong protections for young people and consumers.
Building a Proportionate Framework
The Karachi study may ultimately be most valuable as a reminder that Pakistan needs greater regulatory clarity.
A proportionate framework could include product registration requirements, ingredient disclosure standards, nicotine-content limits, age-of-sale restrictions, retail compliance measures, and ongoing market surveillance.
Such an approach would improve oversight and consumer protection without necessarily assuming that the presence of flavour compounds alone justifies prohibition.
Importantly, it would also allow policymakers to generate Pakistan-specific evidence regarding patterns of use, youth uptake, smoking substitution, and public health outcomes.
Looking Ahead
The Karachi study provides useful information about the composition of nicotine pouches currently available in Pakistan. It contributes to a growing evidence base that can help inform future regulatory decisions.
At the same time, the study does not answer broader questions about toxicological risk, smoking cessation, youth uptake, or long-term public health impact.
Those questions require additional research.
As Pakistan considers how to regulate emerging nicotine products, the challenge will be ensuring that policy decisions are guided by evidence, proportionality, and public health objectives rather than assumptions about product categories.
The goal should not simply be regulation for its own sake. It should be the development of a framework that protects consumers, safeguards young people, supports regulatory oversight, and reflects the best available scientific evidence.
Source
